US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Invesco Nasdaq Biotechnology ETF

34.37

-0.0500-0.15%

Post-market: 34.370.00000.00%19:30 EDT

Volume:134.91K

Turnover:4.64M

Market Cap:105.52M

PE:- -

High:34.78

Open:34.78

Low:34.20

Close:34.42

52wk High:36.84

52wk Low:25.00

Shares:3.07M

Float Shares:3.07M

Volume Ratio:2.41

T/O Rate:4.39%

Dividend:0.39

Dividend Rate:1.14%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Market Shock: A-Share Leader and "Meme Stock" Both Plunge Dramatically

Kexing Biopharm's GB20 Injection Receives Clinical Trial Approval From Regulators

Anke Biotechnology Advances Novel Drug Candidate as Clinical Trial Application Gains Regulatory Acceptance

Citi Highlights Policy Boost for Innovative Drugs and Medical Devices, Names Key Sector Picks

Innovative Drug Sector Heats Up: Spotlight on Pure-Play R&D Developers

Correction to Vertex Material Listing Article on Sept. 17

Innovative Drug Stocks Surge Across the Board in Morning Session, with Keymed Bio-B and Akeso Both Climbing Over 9%

Hong Kong Stock Movers | SBP Group Surges Over 6% as Management Reaffirms Annual Revenue Target, with Newly Approved Innovative Drugs Set to Drive Sustained Sales Growth

Shanghai Shen Lian Biomedical's UB-221 Meets Primary Goal in Phase II Urticaria Trial

Leadership Departure and Flawed Compensation Clauses Cast Doubt on Ruifeng's Acquisition Deal

From Cash Burn to Cash Flow: Is This Innovative Drug Rally Genuinely Different This Time?

Amgen Inc. Stock Outperforms Competitors on Strong Trading Day

Transthera-B Doses First Patient in Phase II Trial of Tinengotinib Combined with Novel Endocrine Therapy for Advanced Metastatic Castration-Resistant Prostate Cancer in China

Kaiyuan Securities: Generic Drug Division Sees Recovery in Earnings Growth, With Innovative Drug and CDMO Transition Players Nearing Their Monetization Phase

朱保国功成身退，39岁刘大平能否引领丽珠穿越转型深水区？

Hefei Lifeon's Clinical Trial Application for a New Pain Relief Drug Combination Has Been Officially Accepted by the Regulator

Gan & Lee Pharmaceuticals Receives Clinical Trial Approval for Investigational Drug GLR1075 Injection

China Targets First-in-Class Drug Share Above 25% Globally by 2030 Under New Five-Year Plan

Ten Ministries Unveil 15th Five-Year Plan for Pharmaceutical Industry, Targeting over 20% Annual Growth in Innovative Drug Sector

Vertex wins approval for 24/7 underground operations at Reward Gold Mine

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://hk.tigershowtime.com/stock/IBBQ/news?page=10"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"IBBQ","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBBQ\",,,,,undefined,":{"symbol":"IBBQ","market":"US","secType":"STK","nameCN":"Invesco Nasdaq Biotechnology ETF","latestPrice":34.37,"timestamp":1790971200000,"preClose":34.42,"halted":0,"volume":134914,"hourTrading":{"tag":"盘后","latestPrice":34.37,"preClose":34.37,"latestTime":"19:30 EDT","volume":23,"amount":793.71,"timestamp":1790983804820,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.0014526438117374858,"floatShares":3070000,"shares":3070000,"eps":0,"marketStatus":"Market Closed","change":-0.05,"latestTime":"10-02 16:00:00 EDT","open":34.78,"high":34.78,"low":34.2,"amount":4640242.504378,"amplitude":0.016851,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791187200000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":34.42,"sharesOutstanding":2520001,"nav":34.4248,"aum":106440372.14,"dividendRate":0.01135,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":34.5,"preClose":34.42,"latestTime":"07:58 EDT","volume":100,"amount":3450,"timestamp":1790942314618,"change":0.08,"changeRate":0.002324,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":34.37,"preClose":34.37,"latestTime":"19:30 EDT","volume":23,"amount":793.71,"timestamp":1790983804820,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":2.412124809157592,"impliedVol":0.1226,"impliedVolPercentile":0.5299},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBBQ\",,,,,undefined,":{"symbol":"IBBQ","floatShares":3070000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":2.412124809157592,"shares":3070000,"dividePrice":0.3901,"high":34.78,"amplitude":0.016851,"preClose":34.42,"low":34.2,"week52Low":25,"pbRate":"--","week52High":36.84,"institutionHeld":0,"latestPrice":34.37,"eps":0,"divideRate":0.01135,"volume":134914,"delay":0,"ttmEps":0,"open":34.78,"prevYearClose":28.3962,"prevWeekClose":35,"prevMonthClose":35.14,"prevQuarterClose":35.14,"fiveDayClose":35,"twentyDayClose":36.26,"sixtyDayClose":33.97},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IBBQ\",params:#limit:5,,,undefined,":[{"date":"2026-09-21","symbol":"IBBQ","amount":0.23037,"announcedDate":"2026-09-18","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-09-21","defaultRemindTime":1789997400000,"name":"Invesco Nasdaq Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-09-25","payableDate":"2026-09-21","currency":"USD","dateTimestamp":1789963200000,"payDate":"2026-09-25"},{"date":"2026-06-22","symbol":"IBBQ","amount":0.03422,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-22","defaultRemindTime":1782135000000,"name":"Invesco Nasdaq Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-26","payableDate":"2026-06-22","currency":"USD","dateTimestamp":1782100800000,"payDate":"2026-06-26"},{"date":"2026-03-23","symbol":"IBBQ","amount":0.03609,"announcedDate":"2026-03-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-23","defaultRemindTime":1774272600000,"name":"Invesco Nasdaq Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-27","payableDate":"2026-03-23","currency":"USD","dateTimestamp":1774238400000,"payDate":"2026-03-27"},{"date":"2025-12-22","symbol":"IBBQ","amount":0.0906,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"Invesco Nasdaq Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-26","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-26"},{"date":"2025-09-22","symbol":"IBBQ","amount":0.09576,"announcedDate":"2025-09-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-22","defaultRemindTime":1758547800000,"name":"Invesco Nasdaq Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-26","payableDate":"2025-09-22","currency":"USD","dateTimestamp":1758513600000,"payDate":"2025-09-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IBBQ\",market:\"US\",,,undefined,":[{"executeDate":"2021-09-20","recordDate":"2021-09-21","paymentDate":"2021-09-30","value":0.04324,"currency":"USD"},{"executeDate":"2021-12-20","recordDate":"2021-12-21","paymentDate":"2021-12-31","value":0.10511,"currency":"USD"},{"executeDate":"2022-03-21","recordDate":"2022-03-22","paymentDate":"2022-03-31","value":0.03778,"currency":"USD"},{"executeDate":"2022-06-21","recordDate":"2022-06-22","paymentDate":"2022-06-30","value":0.04264,"currency":"USD"},{"executeDate":"2022-09-19","recordDate":"2022-09-20","paymentDate":"2022-09-23","value":0.03769,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IBBQ\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IBBQ\",pageSize:20,pageCount:10,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1197588006","title":"Market Shock: A-Share Leader and \"Meme Stock\" Both Plunge Dramatically","url":"https://stock-news.laohu8.com/highlight/detail?id=1197588006","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1197588006?lang=en_us&edition=fundamental","pubTime":"2026-09-21 16:20","pubTimestamp":1789978856,"startTime":"0","endTime":"0","summary":"The Shanghai Composite Index opened higher and climbed throughout the morning session on the 21st, while the ChiNext Index rallied in the final stretch of trading. By the close, the Shanghai...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LNGR","399300","03188","IBBQ","159982","MEDX","06978"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1100391511","title":"Kexing Biopharm's GB20 Injection Receives Clinical Trial Approval From Regulators","url":"https://stock-news.laohu8.com/highlight/detail?id=1100391511","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1100391511?lang=en_us&edition=fundamental","pubTime":"2026-09-21 16:08","pubTimestamp":1789978097,"startTime":"0","endTime":"0","summary":"Kexing Biopharm Co.,Ltd. (688136.SH) has announced that its wholly-owned subsidiary, Shenzhen Kexing Pharmaceutical Co., Ltd., has received the Clinical Trial Approval Notice issued by the National...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BMED","PSYK","BK0239","IBBQ","MDTX","688136","IBBJ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1150102229","title":"Anke Biotechnology Advances Novel Drug Candidate as Clinical Trial Application Gains Regulatory Acceptance","url":"https://stock-news.laohu8.com/highlight/detail?id=1150102229","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1150102229?lang=en_us&edition=fundamental","pubTime":"2026-09-21 16:06","pubTimestamp":1789977986,"startTime":"0","endTime":"0","summary":"Anhui Anke Biotechnology (Group) Co., Ltd. (SZSE: 300009) has announced that its self-developed innovative drug, injection AK2405, has received acceptance of its clinical trial application from the...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159992","LNGR","BK0042","BK1161","IBBQ","MEDX","BK0060","BK0070","BK1574","IBBJ","PSYK","BK0239","BMED","MDTX","300009","06978"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1112501840","title":"Citi Highlights Policy Boost for Innovative Drugs and Medical Devices, Names Key Sector Picks","url":"https://stock-news.laohu8.com/highlight/detail?id=1112501840","media":"Stock News","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1112501840?lang=en_us&edition=fundamental","pubTime":"2026-09-21 15:17","pubTimestamp":1789975044,"startTime":"0","endTime":"0","summary":"Citi has issued a research report following the joint release of the 15th Five-Year Plan for the Pharmaceutical Industry Development by the Ministry of Industry and Information Technology and other...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4207","TFNS","LU2462157665.USD","06978","LU2125154935.USD","LU0203345920.USD","LU0708995153.HKD","LU0455707207.USD","BK1191","LU0516422366.SGD","LU1162221912.USD","BK1515","LU0315179316.USD","01093","LU0880133367.SGD","LU2488822045.USD","LU1506573853.SGD","LU1688375341.USD","02269","LU0463099449.HKD","LU0979878070.USD","LU1226288170.HKD","LU0170899867.USD","LU0516422440.USD","LU0196878994.USD","MEDX","LU0039217434.USD","LU0456846285.SGD","LNGR","LU0708995583.HKD","IE0008368742.USD","IE00BZ08YS42.EUR","LU0516423091.SGD","LU1074936037.SGD","LU0130517989.USD","IE00B5MMRT66.SGD","LU1831875114.USD","LU0823426308.USD","IBBQ","LU0067412154.USD","LGHT","LU0314106906.USD","IYF","IE00BSNM7G36.USD","AGNG","LU0149534421.HKD","LU1668664300.SGD","LU2543165471.USD","LU0417516738.SGD","IE00BZ08YR35.GBP","LU1366192091.USD","BK1610","IE00B543WZ88.USD","BK1100","LU0128525689.USD","SG9999004220.SGD","LU0128522744.USD","LU0607220059.USD","LU0823426480.USD","LU0052756011.USD","BK1576","LU0072461881.USD","LU0516423174.USD","LU1807302812.USD","LU0417516902.SGD","LU0310800965.SGD","LU1226287792.SGD","LU0326950275.SGD","LU1242518857.USD","LU0320765646.SGD","LU0359202008.SGD","FTXO","BK4566","LU0634319403.HKD","LU0140636845.USD","LU1880383366.USD","LU0348735423.USD","C","LU2125154778.USD","BK1574","LU2360032135.SGD","MDEV","LU0181495838.USD","LU0072913022.USD","LU0106831901.USD","LU0029874061.USD","LU0980610538.SGD","BK4504","06990","LU1951186391.HKD","LU0203347892.USD","LU1328277881.USD","BK4534","LU0540923850.HKD","LU1813983027.USD","03347","HK0000165453.HKD","IEIH","LU2417539215.USD","LU1969619763.USD","BK1141","LU0477156953.USD","LU0516422952.EUR","LU0320764243.SGD","BK4588","159992","LU1244550221.USD","LU0130102774.USD","LU0128526141.USD","LU1188198961.HKD","LU1960683339.HKD","LU2236285917.USD","09996","BK4559","LU1144417596.USD","LU2242644610.SGD","01276","SG9999002562.SGD","LU1023057109.AUD","LU2097828631.EUR","LU0588546209.SGD","LU1152091754.HKD","LU1242518931.SGD","SG9999002463.SGD","IE00B031HY20.USD","BK1161","IE00BZ08YT58.USD","LU0327786744.USD","LU0819121731.USD","LU0856984785.SGD","LU2097828714.EUR","LU0501845795.SGD","LU0502904849.HKD","LU0051755006.USD","LU1794554557.SGD","LU0162691827.USD","PTH","BK1589","LU1226287529.USD","BK1521","KURE","LU0348827113.USD","HART","LU0052750758.USD","01801","LU1226288253.USD","LU2097828805.USD","159883","LU1244550494.USD","LU2328871848.SGD","LU1791807156.HKD","LU1720050803.USD","LU0456827905.SGD","LU0359201612.USD","LU1226287875.USD","LU0572944931.SGD","LU2097828474.EUR","LU0359201885.HKD","LU0244354667.USD","LU2097828557.USD","LU0029874905.USD","LU2456880835.USD","LU2039709279.SGD","LU0320764599.SGD","LU1267930227.SGD","BK4585","LU0348825331.USD","LU1201861249.SGD","LU0098860793.USD","BK1583","GDOC","RSPH","LU0043850808.USD","LU1152091168.USD","LU0648001328.SGD","LU1244550577.SGD","LU0314109678.HKD","LU1008478684.HKD","LU1993786604.SGD","LU0561508036.HKD","LU3063872942.SGD","IE00B0JY6N72.USD","LU0307460666.USD","IE0008369823.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1181721651","title":"Innovative Drug Sector Heats Up: Spotlight on Pure-Play R&D Developers","url":"https://stock-news.laohu8.com/highlight/detail?id=1181721651","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1181721651?lang=en_us&edition=fundamental","pubTime":"2026-09-21 14:01","pubTimestamp":1789970464,"startTime":"0","endTime":"0","summary":"A bullish MACD crossover signal has emerged, indicating strong upward momentum for select pharmaceutical stocks. This technical indicator, often seen as a precursor to sustained gains, has caught the...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PBE","SBIO","GDOC","BK4585","BK4588","BK1161","BBP","LFSC","MEDX","GSKH","APXH","IBBQ","BK1574","159992","BIOY","06978","XLVI","LNGR","IBB","WRND"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669412132","title":"Correction to Vertex Material Listing Article on Sept. 17","url":"https://stock-news.laohu8.com/highlight/detail?id=2669412132","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669412132?lang=en_us&edition=fundamental","pubTime":"2026-09-21 12:48","pubTimestamp":1789966080,"startTime":"0","endTime":"0","summary":"Tan Chin Teong is the founder and technical director of Vertex Material. \"Malaysia's Vertex Material Sets Sights on 2027 U.S. Listing,\" at 0931 GMT on Sept. 17, misstated the name as Tan Chin Tong.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BBH","LU0823416689.USD","IE00B19Z9Z06.USD","SGXZ57979304.SGD","IDNA","LU0889565916.HKD","TBXU","BK4588","LU2362541513.USD","LU1035775433.USD","LU2462157665.USD","LU0079474960.USD","LU0256863811.USD","LU1778281490.HKD","VRTX","LU1093756168.USD","PBE","IE00B19Z3B42.SGD","BK4567","LU2324357040.USD","SG9999001176.USD","SG9999013999.USD","IE00B19Z9P08.USD","LU0417517546.SGD","LU0566484027.USD","IE00BFTCPJ56.SGD","LU2236285917.USD","SG9999001176.SGD","LU2362540622.SGD","LU0234570918.USD","LU1585245621.USD","IBB","LU2089984988.USD","BIB","LU0058720904.USD","LU1069344957.HKD","GNMX","LU0320765992.SGD","IBBQ","BK4023","VERX","LU2468319806.SGD","LU2362541273.HKD","LU0109394709.USD","IE00B2B36J28.USD","IE00B4R5TH58.HKD","LU1093756325.SGD","IE00BJJMRZ35.SGD","IE00B894F039.SGD","LU0757428866.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1196765579","title":"Innovative Drug Stocks Surge Across the Board in Morning Session, with Keymed Bio-B and Akeso Both Climbing Over 9%","url":"https://stock-news.laohu8.com/highlight/detail?id=1196765579","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1196765579?lang=en_us&edition=fundamental","pubTime":"2026-09-21 11:41","pubTimestamp":1789962092,"startTime":"0","endTime":"0","summary":"Innovative drug concept stocks experienced a broad rally in early trading, with multiple leading companies posting significant gains. As of the latest update, Keymed Bio-B (02162) jumped 9.09% to...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0634319403.HKD","LU2778985437.USD","LU0348784397.USD","IE00BPRC5H50.USD","159992","IE00B5MMRT66.SGD","LU2476274308.USD","LU0540923850.HKD","09926","LU0561508036.HKD","LU0348767384.USD","LU1720050803.USD","BK1574","LU0417516571.SGD","MEDX","LU0348783233.USD","LU0348825331.USD","LU1961090484.USD","LU0417516902.SGD","LU1794554557.SGD","LU2488822045.USD","LU0348766576.USD","LNGR","BK1161","IE00B543WZ88.USD","06978","KURE","IBBQ","LU2476274720.SGD","LU0417516738.SGD","LU2399975544.HKD","LU0348735423.USD","02162","LU0348827113.USD","BK1583","BK1587"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1110824153","title":"Hong Kong Stock Movers | SBP Group Surges Over 6% as Management Reaffirms Annual Revenue Target, with Newly Approved Innovative Drugs Set to Drive Sustained Sales Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=1110824153","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1110824153?lang=en_us&edition=fundamental","pubTime":"2026-09-21 10:10","pubTimestamp":1789956642,"startTime":"0","endTime":"0","summary":"Shares of SBP GROUP (01177) climbed more than 6% in Hong Kong trading, last up 6.58% to HK$5.83 with turnover reaching HK$192 million.According to a research note from Daiwa, at a recent healthcare...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","HK0000165453.HKD","BK1574","BK4585","MEDX","KCAI","BK4588","BK1191","BK1521","01177","BK1515","159992","IE00BZ08YT58.USD","06978","BK1589","IE00BZ08YR35.GBP","LNGR","IBBQ","VXUS","IE00BZ08YS42.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1140751875","title":"Shanghai Shen Lian Biomedical's UB-221 Meets Primary Goal in Phase II Urticaria Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=1140751875","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1140751875?lang=en_us&edition=fundamental","pubTime":"2026-09-20 15:54","pubTimestamp":1789890856,"startTime":"0","endTime":"0","summary":"Shanghai Shen Lian Biomedical Corporation (688098.SH) has announced that its controlled subsidiary, Yangzhou Shizhiyuan Biotechnology Co., Ltd., achieved the primary endpoint in a Phase II clinical...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0239","BMED","MDTX","688098","IBBQ","PSYK","IBBJ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1161329651","title":"Leadership Departure and Flawed Compensation Clauses Cast Doubt on Ruifeng's Acquisition Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=1161329651","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1161329651?lang=en_us&edition=fundamental","pubTime":"2026-09-20 15:30","pubTimestamp":1789889447,"startTime":"0","endTime":"0","summary":"Shandong Ruifeng Chemical Co.,Ltd. (300243.SZ) has unveiled further details of its acquisition plan, which has been in the works for over a month. The company recently announced its intention to...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0086","TMED","DFMC","PSP","MMID","BK4588","BK0229","BK4585","IEFN","FFSM","PBPH","PEVC","300243","IYH","CANC","TBXU","IBBQ","BK0177","RSPH","PRVT","AAUM","XLFI","GTPE","BK0028","ACTV","MNA","VXF","RFG","UYG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1166262684","title":"From Cash Burn to Cash Flow: Is This Innovative Drug Rally Genuinely Different This Time?","url":"https://stock-news.laohu8.com/highlight/detail?id=1166262684","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1166262684?lang=en_us&edition=fundamental","pubTime":"2026-09-20 13:40","pubTimestamp":1789882836,"startTime":"0","endTime":"0","summary":"For a long stretch, innovative drug companies left investors with an impression of \"burning cash for stories.\" Huge R&D spending, commercialization that seemed perpetually distant, and valuations...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MEDX","06978","IBBQ","BK1161","159992","BK1574","LNGR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668973164","title":"Amgen Inc. Stock Outperforms Competitors on Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2668973164","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668973164?lang=en_us&edition=fundamental","pubTime":"2026-09-19 04:34","pubTimestamp":1789763640,"startTime":"0","endTime":"0","summary":"DJ Amgen Inc. Stock Outperforms Competitors On Strong Trading DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Amgen Inc.  rallied 1.55% to $385.65 Friday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index  rising 0.17% to 7,650.50 and the Dow Jones Industrial Average  falling 0.18% to 51,682.64.This was the stock's third consecutive day of gains.Amgen Inc. closed 13.73% below its 52-week high of $447.03, which the company reached on August 25th.The stock outperformed some of its competitors Friday, as Johnson & Johnson  fell 0.09% to $269.99, Pfizer Inc.  rose 0.07% to $27.66, and AbbVie Inc.  fell 0.02% to $263.96.Trading volume  eclipsed its 50-day average volume of 2.6 M.Data source: Dow Jones Market Data, FactSet. Data compiled September 18, 2026.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2242646821.SGD","IE0009355771.USD","IE00B2B36J28.USD","LU0058720904.USD","IE00BFTCPJ56.SGD","BBH","LU0109394709.USD","LU0868494617.USD","BK4566","LU1057294990.SGD","LU0122379950.USD","LU0889565916.HKD","BK4599","BK4534","LU2112291526.USD","BK4588","IE0002141913.USD","IE00BJJMRZ35.SGD","PJP","PBE","IBB","SG9999001440.SGD","BK4585","LU1983299246.USD","04332","BK4139","BK4533","TBXU","IBBQ","LU0289739699.SGD","IE00BJT1NW94.SGD","IE00B4R5TH58.HKD","AMGN","LU1571399168.USD","BK4581","LU2468319806.SGD","LU0320765992.SGD","LU1023059063.AUD","BIB","LU2089984988.USD","LU2242652126.USD","LU1061106388.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1138364495","title":"Transthera-B Doses First Patient in Phase II Trial of Tinengotinib Combined with Novel Endocrine Therapy for Advanced Metastatic Castration-Resistant Prostate Cancer in China","url":"https://stock-news.laohu8.com/highlight/detail?id=1138364495","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1138364495?lang=en_us&edition=fundamental","pubTime":"2026-09-18 18:58","pubTimestamp":1789729102,"startTime":"0","endTime":"0","summary":"Transthera-B (02617) has announced that the first patient has been dosed in its Phase II clinical trial in China evaluating tinengotinib (Jentai®; Tinengotinib, TT-00420) combined with novel...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02617","BMED","PSYK","BK1161","IBBQ","MDTX","IBBJ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1195650513","title":"Kaiyuan Securities: Generic Drug Division Sees Recovery in Earnings Growth, With Innovative Drug and CDMO Transition Players Nearing Their Monetization Phase","url":"https://stock-news.laohu8.com/highlight/detail?id=1195650513","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1195650513?lang=en_us&edition=fundamental","pubTime":"2026-09-18 17:36","pubTimestamp":1789724171,"startTime":"0","endTime":"0","summary":"Kaiyuan Securities has released a research note indicating that China's domestic pharmaceutical raw material (API) industry is gradually stabilizing and recovering. Several companies are actively...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159992","161027","MEDX","BK1574","IBBQ","LNGR","06978","CDMO","BK4139","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1184123652","title":"朱保国功成身退，39岁刘大平能否引领丽珠穿越转型深水区？","url":"https://stock-news.laohu8.com/highlight/detail?id=1184123652","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1184123652?lang=en_us&edition=fundamental","pubTime":"2026-09-18 17:20","pubTimestamp":1789723244,"startTime":"0","endTime":"0","summary":"当国内老牌制药企业集体站在仿制药红利消退、创新药竞速加剧的时代分水岭，一场备受瞩目的企业权力交接正式完成。近日，丽珠集团公告披露，被誉为医药资本传奇人物、“太太口服液”创始人的朱保国宣布退休，辞去包括董事长在内的所有职务，同时他也卸任了另一家上市公司健康元的董事长职位。辞任后，朱保国依然是公司的实际控制人。朱保国卸任后，年仅39岁的总裁刘大平被推举为丽珠集团新任董事长，正式接掌这家老牌药企的航向。...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","IBBQ","06978","LNGR","BK1161","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1125664386","title":"Hefei Lifeon's Clinical Trial Application for a New Pain Relief Drug Combination Has Been Officially Accepted by the Regulator","url":"https://stock-news.laohu8.com/highlight/detail?id=1125664386","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1125664386?lang=en_us&edition=fundamental","pubTime":"2026-09-18 15:57","pubTimestamp":1789718264,"startTime":"0","endTime":"0","summary":"Hefei Lifeon Pharmaceutical Co., Ltd. (003020.SZ) has announced that it has recently received the formal acceptance notification from the National Medical Products Administration for its clinical...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PSYK","IBBJ","BMED","IBBQ","003020","BK0250","MDTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1161909174","title":"Gan & Lee Pharmaceuticals Receives Clinical Trial Approval for Investigational Drug GLR1075 Injection","url":"https://stock-news.laohu8.com/highlight/detail?id=1161909174","media":"Stock News","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1161909174?lang=en_us&edition=fundamental","pubTime":"2026-09-18 15:42","pubTimestamp":1789717337,"startTime":"0","endTime":"0","summary":"Gan & Lee Pharmaceuticals (603087.SH) announced that it has recently received the \"Drug Clinical Trial Approval Notice\" issued by the National Medical Products Administration for its investigational...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBBQ","IBBJ","BK0239","PSYK","603087","MDTX","BMED"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1146725689","title":"China Targets First-in-Class Drug Share Above 25% Globally by 2030 Under New Five-Year Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=1146725689","media":"Deep News","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1146725689?lang=en_us&edition=fundamental","pubTime":"2026-09-18 09:31","pubTimestamp":1789695077,"startTime":"0","endTime":"0","summary":"Ten government departments, including the Ministry of Industry and Information Technology and the National Development and Reform Commission, jointly released the \"15th Five-Year Plan for...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MEDX","06978","IBBQ","BK1161","159992","BK1574","LNGR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1132425859","title":"Ten Ministries Unveil 15th Five-Year Plan for Pharmaceutical Industry, Targeting over 20% Annual Growth in Innovative Drug Sector","url":"https://stock-news.laohu8.com/highlight/detail?id=1132425859","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1132425859?lang=en_us&edition=fundamental","pubTime":"2026-09-18 09:24","pubTimestamp":1789694661,"startTime":"0","endTime":"0","summary":"On September 18, ten government departments, including the Ministry of Industry and Information Technology and the National Development and Reform Commission, jointly released the 15th Five-Year Plan...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["159992","BK1161","BK1574","LNGR","IBBQ","MEDX","06978"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668914913","title":"Vertex wins approval for 24/7 underground operations at Reward Gold Mine","url":"https://stock-news.laohu8.com/highlight/detail?id=2668914913","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668914913?lang=en_us&edition=fundamental","pubTime":"2026-09-18 08:18","pubTimestamp":1789690694,"startTime":"0","endTime":"0","summary":"An announcement from Vertex Minerals Ltd. ( ($AU:VTX) ) is now available. Vertex Minerals has secured a varied Environment Protection License from ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vertex-wins-approval-for-24-7-underground-operations-at-reward-gold-mine?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vertex-wins-approval-for-24-7-underground-operations-at-reward-gold-mine?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00B19Z9Z06.USD","LU1778281490.HKD","IDNA","IE0009355771.USD","VRTX","IE00BZ9MQY76.HKD","LU1069344957.HKD","LU2468319806.SGD","LU2362541513.USD","IBBQ","BK4585","IE00B894F039.SGD","IE0002270589.USD","LU2362540622.SGD","BK4533","BK4139","LU2089984988.USD","LU1674673691.USD","SGXZ57979304.SGD","LU0432979614.USD","TBXU","BIB","LU0058720904.USD","IE00B19Z9P08.USD","BK4532","BBH","BK4567","IBB","LU0889565916.HKD","LU1035775433.USD","LU1430594728.SGD","IE00BFTCPJ56.SGD","SG9999013999.USD","LU1559883803.SGD","LU2236285917.USD","LU0757428866.USD","VERX","LU0079474960.USD","IE0002141913.USD","SG9999001176.SGD","LU1815336091.USD","LU2237438978.USD","LU0289739699.SGD","LU2324357040.USD","PBE","SG9999001176.USD","IE00BJT1NW94.SGD","LU0109394709.USD","GNMX","LU2462157665.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":10,"totalSize":200,"code":"91000000","status":"200"}]}}